Literature DB >> 35264460

CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory-like Cells.

Michelle L Christian1, Michael J Dapp2, Samuel C Scharffenberger1, Hank Jones1, Chaozhong Song2, Lisa M Frenkel1,3,4,5, Anthony Krumm2, James I Mullins6,5,7, David J Rawlings8,3,9.   

Abstract

One key barrier to curative therapies for HIV is the limited understanding of HIV persistence. HIV provirus integration sites (ISs) within BACH2 are common, and almost all sites mapped to date are located upstream of the start codon in the same transcriptional orientation as the gene. These unique features suggest the possibility of insertional mutagenesis at this location. Using CRISPR/Cas9-based homology-directed repair in primary human CD4+ T cells, we directly modeled the effects of HIV integration within BACH2 Integration of the HIV long terminal repeat (LTR) and major splice donor increased BACH2 mRNA and protein levels, altered gene expression, and promoted selective outgrowth of an activated, proliferative, and T regulatory-like cell population. In contrast, introduction of the HIV-LTR alone or an HIV-LTR-major splice donor construct into STAT5B, a second common HIV IS, had no functional impact. Thus, HIV LTR-driven BACH2 expression modulates T cell programming and leads to cellular outgrowth and unique phenotypic changes, findings that support a direct role for IS-dependent HIV-1 persistence.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35264460      PMCID: PMC8976747          DOI: 10.4049/jimmunol.2100491

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

2.  HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage-associated p24 antigen expression.

Authors:  K D Mack; X Jin; S Yu; R Wei; L Kapp; C Green; B Herndier; N W Abbey; A Elbaggari; Y Liu; M S McGrath
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

3.  Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

Authors:  Julian Schulze Zur Wiesch; Adriana Thomssen; Philip Hartjen; Ilona Tóth; Clara Lehmann; Dirk Meyer-Olson; Kristina Colberg; Sebastian Frerk; Dalia Babikir; Stefan Schmiedel; Olaf Degen; Stefan Mauss; Jürgen Rockstroh; Schlomo Staszewski; Pavel Khaykin; Alexander Strasak; Ansgar W Lohse; Gerd Fätkenheuer; Joachim Hauber; Jan van Lunzen
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

4.  Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.

Authors:  Nicholas Hubbard; David Hagin; Karen Sommer; Yumei Song; Iram Khan; Courtnee Clough; Hans D Ochs; David J Rawlings; Andrew M Scharenberg; Troy R Torgerson
Journal:  Blood       Date:  2016-02-22       Impact factor: 22.113

5.  Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo.

Authors:  Francesco R Simonetti; Hao Zhang; Garshasb P Soroosh; Jiayi Duan; Kyle Rhodehouse; Alison L Hill; Subul A Beg; Kevin McCormick; Hayley E Raymond; Christopher L Nobles; John K Everett; Kyungyoon J Kwon; Jennifer A White; Jun Lai; Joseph B Margolick; Rebecca Hoh; Steven G Deeks; Frederic D Bushman; Janet D Siliciano; Robert F Siliciano
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

6.  Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.

Authors:  F Bouscarat; M Levacher-Clergeot; M C Dazza; K W Strauss; P M Girard; C Ruggeri; M Sinet
Journal:  AIDS Res Hum Retroviruses       Date:  1996-01-01       Impact factor: 2.205

7.  Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.

Authors:  Andrew Lim; Dino Tan; Patricia Price; Adeeba Kamarulzaman; Hong-Yien Tan; Ian James; Martyn A French
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

8.  Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.

Authors:  J A Johnston; C M Bacon; D S Finbloom; R C Rees; D Kaplan; K Shibuya; J R Ortaldo; S Gupta; Y Q Chen; J D Giri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells.

Authors:  King L Hung; Iana Meitlis; Malika Hale; Chun-Yu Chen; Swati Singh; Shaun W Jackson; Carol H Miao; Iram F Khan; David J Rawlings; Richard G James
Journal:  Mol Ther       Date:  2017-11-22       Impact factor: 11.454

Review 10.  The forces driving clonal expansion of the HIV-1 latent reservoir.

Authors:  Runxia Liu; Francesco R Simonetti; Ya-Chi Ho
Journal:  Virol J       Date:  2020-01-07       Impact factor: 4.099

View more
  2 in total

Review 1.  Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses.

Authors:  Noemi Linden; R Brad Jones
Journal:  Trends Immunol       Date:  2022-07-08       Impact factor: 19.709

Review 2.  The State-of-the-Art of Gene Editing and its Application to Viral Infections and Diseases Including COVID-19.

Authors:  Yousef M Hawsawi; Anwar Shams; Abdulrahman Theyab; Jumana Siddiqui; Mawada Barnawee; Wed A Abdali; Nada A Marghalani; Nada H Alshelali; Rawan Al-Sayed; Othman Alzahrani; Alanoud Alqahtani; Abdulrahman M Alsulaiman
Journal:  Front Cell Infect Microbiol       Date:  2022-06-09       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.